4.5 Review

Tim-3 and Tim-4 as the potential targets for antitumor therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

CEACAM1 regulates TIM-3-mediated tolerance and exhaustion

Yu-Hwa Huang et al.

NATURE (2015)

Article Cell & Tissue Engineering

Rep Sox Slows Decay of CD34+ Acute Myeloid Leukemia Cells and Decreases T Cell lmmunoglobulin Mucin-3 Expression

Audrey N. Jajosky et al.

STEM CELLS TRANSLATIONAL MEDICINE (2014)

Article Oncology

Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade

Ines Pires da Silva et al.

CANCER IMMUNOLOGY RESEARCH (2014)

Article Oncology

Prognostic Value of T Cell Immunoglobulin Mucin-3 in Prostate Cancer

Yong-Rui Piao et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)

Article Oncology

Combined blockade of TIM-3 and TIM-4 augments cancer vaccine efficacy against established melanomas

Muhammad Baghdadi et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)

Article Biochemistry & Molecular Biology

The Expression of Tim-3 in Peripheral Blood of Ovarian Cancer

Jie Wu et al.

DNA AND CELL BIOLOGY (2013)

Article Hematology

TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells

Yoshikane Kikushige et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)

Article Medicine, Research & Experimental

Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer

Zhiqiang Guo et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2013)

Article Multidisciplinary Sciences

Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis

Yang Cao et al.

PLOS ONE (2013)

Article Pathology

Ectopic Expression of TIM-3 in Lung Cancers A Potential Independent Prognostic Factor for Patients With NSCLC

Xuewei Zhuang et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)

Article Cell Biology

TIM-3 as a therapeutic target for malignant stem cells in acute myelogenous leukemia

Yoshikane Kikushige et al.

HEMATOPOIETIC STEM CELLS VIII (2012)

Review Immunology

Tim-3, a negative regulator of anti-tumor immunity

Ana Carrizosa Anderson

CURRENT OPINION IN IMMUNOLOGY (2012)

Article Biochemistry & Molecular Biology

T-Cell Immunoglobulin- and Mucin-Domain-Containing Molecule 3 Gene Polymorphisms and Renal Cell Carcinoma

Chen Cai et al.

DNA AND CELL BIOLOGY (2012)

Article Biochemistry & Molecular Biology

T cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and susceptibility to pancreatic cancer

Danian Tong et al.

MOLECULAR BIOLOGY REPORTS (2012)

Editorial Material Immunology

Tumor immunity times out: TIM-3 and HMGB1

Daolin Tang et al.

NATURE IMMUNOLOGY (2012)

Review Oncology

The blockade of immune checkpoints in cancer immunotherapy

Drew M. Pardoll

NATURE REVIEWS CANCER (2012)

Review Oncology

Autophagy as a target for anticancer therapy

Filip Janku et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2011)

Article Oncology

Genetic variations and haplotypes in TIM-3 gene and the risk of gastric cancer

Bangwei Cao et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)

Article Cell & Tissue Engineering

TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells

Yoshikane Kikushige et al.

CELL STEM CELL (2010)

Article Cell Biology

Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation

Jennifer S. Carew et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)

Article Immunology

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

Kaori Sakuishi et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2010)

Article Multidisciplinary Sciences

T and B cell hyperactivity and autoimmunity associated with niche-specific defects in apoptotic body clearance in TIM-4-deficient mice

Roselynn Rodriguez-Manzanet et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Multidisciplinary Sciences

Identification of Tim4 as a phosphatidylserine receptor

Masanori Miyanishi et al.

NATURE (2007)